Kestra Advisory Services’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,250
| Closed | -$183K | – | 2608 |
|
|
2024
Q1 | $183K | Buy |
30,250
+4,999
| +20% | +$30.3K | ﹤0.01% | 2301 |
|
|
2023
Q4 | $153K | Buy |
25,251
+1
| +0% | +$6 | ﹤0.01% | 2155 |
|
|
2023
Q3 | $107K | Sell |
25,250
-1,400
| -5% | -$5.91K | ﹤0.01% | 2015 |
|
|
2023
Q2 | $82.6K | Hold |
26,650
| – | – | ﹤0.01% | 2016 |
|
|
2023
Q1 | $37K | Sell |
26,650
-658
| -2% | -$915 | ﹤0.01% | 2004 |
|
|
2022
Q4 | $54.3K | Buy |
27,308
+1,471
| +6% | +$2.93K | ﹤0.01% | 2174 |
|
|
2022
Q3 | $52K | Sell |
25,837
-649
| -2% | -$1.31K | ﹤0.01% | 2028 |
|
|
2022
Q2 | $84K | Buy |
26,486
+814
| +3% | +$2.58K | ﹤0.01% | 2003 |
|
|
2022
Q1 | $107K | Buy |
25,672
+299
| +1% | +$1.25K | ﹤0.01% | 1927 |
|
|
2021
Q4 | $122K | Sell |
25,373
-1,511
| -6% | -$7.27K | ﹤0.01% | 1929 |
|
|
2021
Q3 | $144K | Buy |
+26,884
| New | +$144K | ﹤0.01% | 2023 |
|